Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases

Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases

Abstract Of the 80 solid tumor cases in which liquid biopsy (LB) was performed using Guardant360 in the PROFILE study, nine were lung cancer cases. Here, we review three cases in which LB was useful in diagnosing ALK fusion‐positive lung cancer, selecting sequential ALK‐tyrosine kinase inhibitors, c...

Full description

Bibliographic Details
Main Authors: Takahiro Mitsumura, Yuichi Kumaki, Kenta Takahashi, Shotaro Matsudera, Rie Sakakibara, Takayuki Honda, Masahiro Ishizuka, Yuki Iijima, Tsuyoshi Shirai, Tsukasa Okamoto, Tomoya Tateishi, Hiroyuki Sakashita, Satoshi Miyake, Sadakatsu Ikeda, Yasunari Miyazaki
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Thoracic Cancer
Subjects:
gene profiling
liquid biopsy
lung cancer
Online Access:https://doi.org/10.1111/1759-7714.14098

Internet

https://doi.org/10.1111/1759-7714.14098

Similar Items